Ana Isabel Burguete

Dr. Ana Isabel Burguete

National Institute of Public Health - INSP
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1998 in Journal of Hepatology
Verified
Journal Article
Closed access
MVMiriam Nohemí Vázquez-García
Miriam Nohemí Vázquez-García
CACarmen Aláez
Carmen Aláez
AOAngélica Olivo
Angélica Olivo
HDHéctor Debaz
Héctor Debaz
EPElva Pérez-Luque
Elva Pérez-Luque
CGClara Gorodezky
Clara Gorodezky

14 March 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
OPOscar Peralta-Zaragoza
Oscar Peralta-Zaragoza
JDJessica Deas
Jessica Deas
Angélica Meneses AcostaAngélica Meneses Acosta
Angélica Meneses Acosta
FOFaustino De la O-Gómez
Faustino De la O-Gómez
GFGloria Fernández-Tilapa
Gloria Fernández-Tilapa
Carlos Pérez-PlasenciaCarlos Pérez-Plasencia
Carlos Pérez-Plasencia
Expression of the microRNA miR-21 has been found to be altered in almost all types of cancers and it has been classified as an oncogenic microRNA or oncomir. Due to the critical functions of its target proteins in various signaling pathways, miR-21 is an attractive target for genetic and pharmacological modulation in various cancers. Cervical cancer is the second most common cause of death from cancer in women worldwide and persistent HPV infection is the main etiologic agent. This malignancy merits special attention for the development of new treatment strategies. In the present study we analyze the role of miR-21 in cervical cancer cells. To identify the downstream cellular target genes of upstream miR-21, we silenced endogenous miR-21 expression in a cervical intraepithelial neoplasia-derived cell lines using siRNAs. The effect of miR-21 on gene expression was assessed in cervical cancer cells transfected with the siRNA expression plasmid pSIMIR21. We identified the tumor suppressor gene PTEN as a target of miR-21 and determined the mechanism of its regulation throughout reporter construct plasmids. Using this model, we analyzed the expression of miR-21 and PTEN as well as functional effects such as autophagy and apoptosis induction. In SiHa cells, there was an inverse correlation between miR-21 expression and PTEN mRNA level as well as PTEN protein expression in cervical cancer cells. Transfection with the pSIMIR21 plasmid increased luciferase reporter activity in construct plasmids containing the PTEN-3′-UTR microRNA response elements MRE21-1 and MRE21-2. The role of miR-21 in cell proliferation was also analyzed in SiHa and HeLa cells transfected with the pSIMIR21 plasmid, and tumor cells exhibited markedly reduced cell proliferation along with autophagy and apoptosis induction. We conclude that miR-21 post-transcriptionally down-regulates the expression of PTEN to promote cell proliferation and cervical cancer cell survival. Therefore, it may be a potential therapeutic target in gene therapy for cervical cancer.

14 November 2012 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
KTKIRVIS TORRES-POVEDA
KIRVIS TORRES-POVEDA
Ana Isabel BurgueteAna Isabel Burguete
Ana Isabel Burguete
MCMiguel Cruz
Miguel Cruz
GMGabriela Angelica Martínez-Nava
Gabriela Angelica Martínez-Nava
MBMargarita Bahena-Roman
Margarita Bahena-Roman
VMVicente Madrid Marina
Vicente Madrid Marina
Background: Women with Human Papilloma Virus (HPV) persistence are characterized by high levels of IL-10 at cervix. We have determined whether polymorphisms of IL-10 gene promoter might be associated with increased risk of squamous intraepithelial cervical lesions (SICL) and whether exist significative differences of IL-10 mRNA expression at cervix and systemic and serum IL-10 protein between SICL cases and non-Cervical Lesions (NCL).Methods: Peripheral blood samples from SICL (n = 204) and NCL (n = 166) were used to detect IL-10 promoter polymorphisms at loci -592A/C (rs1800872), -819C/T (rs1800871), -1082A/G (rs1800896), -1352A/G (rs1800893), by allelic discrimination and to evaluate serum IL-10 protein. Cervical epithelial scrapings from NCL and biopsies from SICLs were used for HPV-typing and to evaluate IL-10 mRNA expression level. The systemic and local IL-10 mRNA expression levels were measured by real time-PCR. Genotypic and allelic frequencies of the selected polymorphisms were analyzed by logistic regression, adjusting by age and HPV-genotype, to determine the association with SICL.Results: No significant differences were found between genotype frequencies at loci −819, -1082, and −1352. Individuals carrying at least one copy of risk allele A of polymorphism −592 had a two-fold increased risk of developing SICL [adjusted odds ratio (OR), 2.02 (95% CI, 1.26-3.25), p = 0.003], compared to NCL. The IL-10 mRNA expression and serum IL-10 protein, were significantly higher in SICL cases (p < 0.01), being higher in patients carrying the risk allele A.Conclusions: The −592 polymorphism is associated with increased risk of SICL and can serve as a marker of genetic susceptibility to SICL among Mexican women. According to IL-10 levels found in SICL, IL-10 can be relevant factor for viral persistence and progression disease.

11 August 2011 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
LMLaura E. Martínez-Gómez
Laura E. Martínez-Gómez
MCMiguel Cruz
Miguel Cruz
GMGabriela Angelica Martínez-Nava
Gabriela Angelica Martínez-Nava
VMVicente Madrid-Marina
Vicente Madrid-Marina
EPEsteban Parra
Esteban Parra
Ana Isabel BurgueteAna Isabel Burguete
Ana Isabel Burguete

1 January 2010 in Metabolism
Verified
Journal Article
Closed access
Ana Isabel BurgueteAna Isabel Burguete
Ana Isabel Burguete
MCMiguel Cruz
Miguel Cruz
VMVicente Madrid-Marina
Vicente Madrid-Marina
RLRuy Lopez-Ridaura
Ruy Lopez-Ridaura
MHMauricio Hernández-Ávila
Mauricio Hernández-Ávila
EVEduardo Velasco-Mondragón
Eduardo Velasco-Mondragón

24 January 2022 in Children
Verified
Journal Article
Open access
PDF file
Sofía M Murga-GarridoSofía M Murga-Garrido
Sofía M Murga-Garrido
YOYaneth Citlalli Orbe-Orihuela
Yaneth Citlalli Orbe-Orihuela
CBCinthya Estefhany Díaz Benítez
Cinthya Estefhany Díaz Benítez
AMANA CRISTINA CASTAÑEDA MARQUEZ
ANA CRISTINA CASTAÑEDA MARQUEZ
FCFernanda Cornejo
Fernanda Cornejo
ALAlfredo Lagunas-Martínez
Alfredo Lagunas-Martínez
Gut microbiota is associated with the development of metabolic disorders. To study its association with childhood obesity, we performed a cross-sectional study with 46 children (6–12 years old). We collected fecal samples, food-frequency questionnaires (FFQs), and anthropometric measurements. Shotgun metagenomics were used to obtain the microbial taxonomic diversity and metabolic potential. We identified two dietary profiles characterized by complex carbohydrates and proteins (pattern 1) and saturated fat and simple carbohydrates (pattern 2). We classified each participant into normal weight (NW) or overweight and obese (OWOB) using their body mass index (BMI) z-score. The ratio of Firmicutes/Bacteroidetes and alpha diversity were not different between the BMI groups. Genera contributing to beta diversity between NW and OWOB groups included Bacteroides rodentium, B. intestinalis, B. eggerthii, Methanobrevibacter smithii, Eubacterium sp., and Roseburia sp. B. rodentium was associated with lower BMI and dietary pattern 1 intake. Eubacterium sp. and Roseburia sp. were associated with BMI increments and high consumption of dietary pattern 2. Methane and energy metabolism were found enriched in under-represented KEGG pathways of NW group compared to OWOB. Complex dietary and microbiome interaction leads to metabolic differences during childhood, which should be elucidated to prevent metabolic diseases in adolescence and adulthood.